Top 5 Medical VC Funds & Investors in Hungary (May 2026)

Portfolio highlights

• EcoG — EcoG connects and enables monetizing charging infrastructure with an API-software platform. EcoG is the first cloud-based platform to enable shared revenue streams and value-added services in fast charging. With EcoG a personalized and customized EV fast charging experience is easy to implement and operate.
• Klim — Klim enables farmers to transition to regenerative agriculture at scale by providing them financial support, knowledge, documentation tools, and a community via our digital companion for farmers.Klim-verified carbon removal credits, generated by Klim farmers, help companies to transition to net zero by offsetting their carbon emissions locallyand with maximum impact and transparency.
• OroraTech — OroraTech provides global real-time information services. The first target market is early detection and monitoring of wildfires, extended by a proprietary constellation of thermal imaging nanosatellites equipped with in-space AI image processing. At the beginning of 2020, OroraTech launched an MVP called Wildfire Service (WFS) that enables quickdetection and monitoring of wildfires on a global scale. The combination of existing thermal-infrared satellite data with external data layers, such as fuel, wind, and risk maps results in an automatic generation of fire alerts and the display of current fire perimeters for users. The MVP was launched in early 2020 and has gained increasing traction with governmental and large corporate customers all over the world.

Portfolio highlights

• Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
• Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
• Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.

Portfolio highlights

• Duelbox — Customized games for any event. Build an unforgettable event with our ever-growing game universe that's made to be personalized.
• YourAnastomosis — Why are we needed?Until recently, there were no objective methods to evaluate the quality of the practice of vessel anastomosis (vascular suture) for cardiac surgeons, vascular surgeons, and surgical trainees. It was not possible to know how one surgically created vessel suture will behave, and what its long-term effectiveness will be.How arewe solving these challenges?Our technological innovations provide objective feedback about the quality of anastomoses during surgical training. Our method can be used as a convenient and gamified system, for surgical education and training for attendees, learners from all stages of training and levels of expertise. What do we offer?Your Anastomosis offers anastomosis (vascular suture) analysis for surgeons, surgical trainees and medical students. Our technology provides simulated environments, by digitizing and blood flow conditions, and evaluating short and long-term results of the specific vessel. The innovation in our technology allows for an objective assessment of an anastomosis, creating clear surgical and technical suggestions for improvement.
• DiabTrend AI Analytics — Diabetes Diary with Food Image Recognition + Portion Estimation, Personalised Blood Glucose Level Prediction - Hypo + Hyperglycemic Warning - Hba1c Estimation. Integrates with Glucose Sensors Software Integrations - Freestyle Libre

Portfolio highlights

• Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
• On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
• NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.

Portfolio highlights

• Doctor24 — Doktor24 group of companies are able to serve all emerging individual and corporate customer needs in the following areas: allergology, internal medicine, dermatology, dietetics, otolaryngology, cardiology, gynecology, orthopedics, rheumatology, ophthalmology, urology, blood sampling without queuing, imaging diagnostics ( X-rays, ultrasound,mammography), complex health screenings (so-called managerial screening).